 |
 |
Search
- Page Path
-
- HOME
- Search
- IBD
- Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance
- Shiro Nakamura, Teita Asano, Hiroaki Tsuchiya, Kanami Sugimoto, Yuya Imai, Seiji Yokoyama, Yasuo Suzuki
- Intest Res. 2022;20(3):329-341. Published online August 4, 2021
- Full text PubReader ePub PDF Supplementary Material
- Efficacy and safety of ustekinumab in Japanese patients with moderately to severely active Crohn's disease: a subpopulation analysis of phase 3 induction and maintenance studies
- Toshifumi Hibi, Yuya Imai, Yoko Murata, Nobuko Matsushima, Richuan Zheng, Christopher Gasink
- Intest Res. 2017;15(4):475-486. Published online October 23, 2017
- Full text PubReader ePub PDF Supplementary Material
|
|
- Editorial Office
-
Room 310, Lotte Gold Rose II, 31 Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
Tel: +82-2-957-6145 Fax: +82-2-957-6146 E-mail: thekasid@irjournal.org
Copyright © 2024 by Korean Association for the Study of Intestinal Diseases.
